Oarsman Capital, Inc. Amgen Inc Transaction History

Oarsman Capital, Inc.

$533 Million
Q3 2024

A detailed history of Oarsman Capital, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Oarsman Capital, Inc. holds 2,811 shares of AMGN stock, worth $826,434. This represents 0.17% of its overall portfolio holdings.

Number of Shares

2,811

Previous 2,801 0.36%

Holding current value

$826,434

Previous $875,000 3.43%

% of portfolio

0.17%

Previous 0.19%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$309.38 - $337.38 $3,093 - $3,373	10 Added 0.36%	2,811 $905,000
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $12,874 - $15,646	-49 Reduced 1.72%	2,801 $875,000
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $311,889 - $376,489	-1,160 Reduced 28.93%	2,850 $810,000
Q4 2023 Feb 16, 2024	SELL	$255.7 - $288.46 $15,597 - $17,596	-61 Reduced 1.5%	4,010 $1.15 Million
Q3 2023 Oct 27, 2023	SELL	$218.65 - $271.46 $58,816 - $73,022	-269 Reduced 6.2%	4,071 $1.09 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $160,762 - $195,942	712 Added 19.63%	4,340 $1.05 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $33,209 - $42,196	-145 Reduced 3.84%	3,628 $952,000
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $42,647 - $48,098	-190 Reduced 4.79%	3,773 $850,000
Q2 2022 Aug 10, 2022	SELL	$230.71 - $256.74 $123,429 - $137,355	-535 Reduced 11.89%	3,963 $964,000
Q1 2022 May 11, 2022	SELL	$219.27 - $242.57 $20,830 - $23,044	-95 Reduced 2.07%	4,498 $1.09 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $115,350 - $132,008	-580 Reduced 11.21%	4,593 $1.03 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $10,613 - $12,435	-50 Reduced 0.96%	5,173 $1.1 Million
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $14,014 - $15,548	-60 Reduced 1.14%	5,223 $1.27 Million
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $131,592 - $153,349	-593 Reduced 10.09%	5,283 $1.31 Million
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $79,195 - $94,307	-366 Reduced 5.86%	5,876 $1.35 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $52,326 - $58,191	-223 Reduced 3.45%	6,242 $1.59 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $711,324 - $872,893	3,596 Added 125.34%	6,465 $1.53 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $699,437 - $927,644	-3,838 Reduced 57.22%	2,869 $582,000
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $30,273 - $38,912	-160 Reduced 2.33%	6,707 $1.62 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $33,603 - $40,263	-193 Reduced 2.73%	6,867 $1.33 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $10,002 - $11,724	60 Added 0.86%	7,060 $1.3 Million
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $13,746 - $15,494	76 Added 1.1%	7,000 $1.33 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $50,130 - $58,518	281 Added 4.23%	6,924 $1.35 Million
Q3 2018 Nov 07, 2018	SELL	$185.29 - $208.89 $28,719 - $32,377	-155 Reduced 2.28%	6,643 $1.38 Million
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $9,132 - $10,258	55 Added 0.82%	6,798 $1.26 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $6,777 - $7,920	-40 Reduced 0.59%	6,743 $1.15 Million
Q4 2017 Feb 08, 2018	SELL	$168.79 - $188.59 $19,410 - $21,687	-115 Reduced 1.67%	6,783 $1.18 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $1.15 Million - $1.32 Million	6,898	6,898 $1.29 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oarsman Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oarsman Capital, Inc. with notifications on news.

Account

Oarsman Capital, Inc. Amgen Inc Transaction History